FDA Inspection 1315222 — Barbara Pistilli, MD

Barbara Pistilli, MD — FEI 3042641054

The FDA completed an inspection of Barbara Pistilli, MD on April 10, 2026 in Villejuif. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 10, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Villejuif (France)

Additional Details

Clinical Investigator (CI)